The Framingham prediction rule is not valid in a European population of treated hypertensive patients
Related Experiment Videos
Sylvie Bastuji-Garin1, Anne Deverly, Dominique Moyse
1Department of Public Health, Henri-Mondor Hospital, (AP-HP), Paris XII University, Créteil, France. sylvie.bastuji-garin@hmn.ap-hop-paris.fr
Insights
The Framingham risk models overestimate coronary heart disease (CHD) risk in European populations. While stroke risk prediction was accurate, country-specific adjustments are needed for effective cardiovascular risk stratification.
Area of Science:
- Cardiology
- Epidemiology
- Public Health
Background:
- Cardiovascular risk stratification is crucial for primary prevention strategies.
- Accurate risk assessment aids in tailoring preventative interventions for diverse populations.
Purpose of the Study:
- To evaluate the accuracy of Framingham risk models in predicting coronary heart disease (CHD) and stroke in European hypertensive patients.
- To assess the models' ability to rank individual cardiovascular risk levels.
Main Methods:
- Prospective cohort study involving 4407 European patients (aged <75) without prior cardiovascular events from the INSIGHT trial.
- Comparison of actual major cardiovascular events against risks predicted by Framingham equations and INSIGHT-derived models.
- Follow-up median of 3.7 years across eight Western European countries and Israel.
Main Results:
- Overestimation of absolute CHD risk by Framingham models was noted across all participating countries, with variations from 2% (UK) to 7% (France).
- Predicted stroke risk closely aligned with actual observed stroke events.
- A threefold higher cardiovascular event risk was observed in the highest risk quintile compared to the lowest within each country.
Conclusions:
- Framingham models are not suitable for predicting absolute CHD risk in the overall European population.
- Country-specific calibration and determination of risk cut-off points are recommended for utilizing Framingham models in European hypertensive patients.
Background:
Stratification of population groups according to cardiovascular risk level is recommended for primary prevention.
Objective:
To assess whether the Framingham models could accurately predict the absolute risk of coronary heart disease (CHD) and stroke in a large cohort of middle-aged European patients with hypertension, and rank individual patients according to actual risk.
Design:
A prospective cohort study comparing the actual risk with that predicted by either the Framingham equations or models derived from the INSIGHT study.
Patients And Setting:
From the INSIGHT prospective trial, conducted in eight countries of Western Europe and Israel, we selected 4407 European patients younger than 75 years without previous cardiovascular events.
Interventions:
None.
Main Outcome Measures:
Major cardiovascular events.
Results:
In this population (45% men, mean age 64.1 years), 124 (2.8%) patients had CHD and 96 (2.2%) had strokes after a median follow-up of 3.7 years. Overestimation of absolute CHD risk by the Framingham equation was observed in all countries (from 2% in the UK to 7% in France), whereas predicted risk of stroke was close to the actual risk. However, patients in the highest risk quintile within each country had a threefold greater risk of a cardiovascular event than those in the lowest quintile.
Conclusions:
The Framingham models should not be used to predict absolute CHD risk in the European population as a whole. However, these models may be used within each country, provided that cut-off points defining high-risk patients have been determined within each country.
Related Concept Videos
Regression Toward the Mean
Pre-Procedural Guidelines for Assessing Blood Pressure
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT